Pana Bio, Inc.

Houston, TX · Founded 2020 · Biotech · Defunct

Endoscopically implanted engineered bacteria encapsulated in a hydrogel biomaterial and porous cage, designed to produce biologic drugs locally in the GI tract for treating inflammatory bowel disease

Claim this profile

Follows are private to you and power your alerts

Updated · pana.bio

Sector
Biotech
Headquarters
Houston, TX
Founded
2020
Latest Form D
$200K, Nov 2021
Total capital
$515K
Federal grants
$255K
1 award · 2022
Rank in peer group#8 of 22
Private capital raised
$260K
2 Form D · last Nov 2021
60 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

20212022FEDERAL ↑EQUITY ↓Cumulative $515K$255K1st Form D$60K2nd Form D$200K
20212022FEDERAL ↑EQUITY ↓Cumulative $515K$255K1st Form D$60K2nd Form D$200K

Latest events

  • Federal grantHealth and Human S · Phase I · Enabling IL-2 as an Anti-inflammatory Agent through Local Dose-controlled Endoscopic Delivery$255K
  • Private capital raisedForm D · SEC · 2nd filing$200K
  • Private capital raisedForm D · SEC · 1st filing$60K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 22 peers

Line = median

Biotech · Device

  • Federal grants#8 · top 36%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • David Yu ZhangExecutive Officer, DirectorNamed in SEC Form D filings
  • Jeffrey Yu TaborDirectorNamed in SEC Form D filings
  • Jinglin Yu HuangExecutive OfficerNamed in SEC Form D filings
  • Omid Yu VeisehDirectorNamed in SEC Form D filings
  • Robert Yu BrittonDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingImplanted Device For Long-term Drug ReleaseUSPTOApplication PCTUS2022042272
  • PendingImplanted Device For Long-term Drug ReleaseUSPTOApplication 63301876
  • PendingImplanted Device For Long-term Drug ReleaseUSPTOApplication 63239768

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .